GSK plc Research And Development Expense

• GSK plc showed an increase of +17.6% in Research And Development Expense from 2024 to 2025.
• This data is from GSK plc's annual report (Form 10-K), filed with the SEC on March 6, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), GSK plc's Research And Development Expense has grown by 107.4%.
• Historical annual values: Fiscal year 2025: $7.53 billion | Fiscal year 2024: $6.40 billion | Fiscal year 2023: $6.22 billion | Fiscal year 2022: $5.49 billion | Fiscal year 2021: $5.02 billion | Fiscal year 2020: $4.79 billion | Fiscal year 2019: $4.57 billion | Fiscal year 2018: $3.89 billion | Fiscal year 2017: $4.48 billion | Fiscal year 2016: $3.63 billion.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026